2024 Iowa Cancer Summit

Thank you to our sponsors, attendees, and speakers for making the 2024 Iowa Cancer Summit the biggest Summit in the Iowa Cancer Consortium’s 22-year history! We look forward to seeing you next year!

View recorded sessions from the 2024 Iowa Cancer Summit.

Join our Newsletter so you’ll be the first to hear about the 2025 Iowa Cancer Summit on Tuesday, October 14th, 2025, in Ankeny, IA.

Iowa Cancer Consortium Inclusion Statement

At the heart of the Iowa Cancer Consortium is a commitment to inclusion and respect for all individuals. Our approach is one of openness and shared humanity. We strive to create a space where diverse voices, bodies, and brains are welcomed and valued. We ensure every person’s unique story and connection to cancer are met with unwavering support. Together, we are building a stronger network that better reflects and includes all of Iowa’s communities. 

Non-Discrimination Statement

The University of Iowa prohibits discrimination in employment, educational programs, and activities on the basis of race, creed, color, religion, national origin, age, sex, pregnancy, disability, genetic information, status as a U.S. veteran, service in the U.S. military, sexual orientation, gender identity, associational preferences or any other classification that deprives the person of consideration as an individual. The University also affirms its commitment to providing equal opportunities and equal access to University facilities. For additional information on nondiscrimination policies, contact the Director, Office of Equal Opportunity and Diversity, the University of Iowa, 202 Jessup Hall, Iowa City, IA 52242-1316, 319-335-07-05 (voice), 319-335-0697 (TDD), [email protected].

Accessibility Statement

Individuals with disabilities are encouraged to attend the Iowa Cancer Summit and other Iowa Cancer Consortium sponsored events. If you are a person with a disability who requires a reasonable accommodation in order to participate in this program, please contact the Iowa Cancer Consortium in advance at 319-384-1741.